# Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years

> **NCT01376427** · NA · UNKNOWN · sponsor: **PETHEMA Foundation** · enrollment: 100 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia Ph Positive

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Methotrexate
- **DRUG:** Vincristine

## Key facts

- **NCT ID:** NCT01376427
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376427, "Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01376427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*